EcoDrugPlus

Adenosine Deaminase

Ensembl ID : ENSMAUG00000001141
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adhesion Regulating Molecule 1

Ensembl ID : ENSMAUG00000021991
Gene Symbol: ADRM1
3 Cross references
255 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSMAUG00000019248
Gene Symbol: ADRA1A
4 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSMAUG00000013092
Gene Symbol: ADRA1B
3 Cross references
263 Possible Orthologues:

Adrenoceptor Alpha 1d

Ensembl ID : ENSMAUG00000009086
Gene Symbol: ADRA1D
4 Cross references
194 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSMAUG00000011850
Gene Symbol: ADRA2A
4 Cross references
230 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSMAUG00000010360
Gene Symbol: ADRA2C
4 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSMAUG00000017373
Gene Symbol: ADRB2
3 Cross references
263 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSMAUG00000019598
Gene Symbol: ADRB3
3 Cross references
215 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSMAUG00000001006
Gene Symbol: AGER
3 Cross references
169 Possible Orthologues:

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSMAUG00000001217
Gene Symbol: ADH5
1 Cross references
400 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSMAUG00000009279
Gene Symbol: AKR1B1
4 Cross references
429 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).